Vitamin K1 (phylloquinone) induces vascular endothelial dysfunction: Role of oxidative stress

Toxicology and Applied Pharmacology

Volumn 213, Issue 1, 2006, Pages 10-17

  Tirapelli, Carlos R ^a   De Andrade, Claudia R ^a   Lieberman, Marcel ^a   Laurindo, Francisco R ^a   De Souza, Heraldo P ^a   de Oliveira, Ana M ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculty of Pharmaceutical Sciences of Ribeirao Preto   (Brazil)

Author keywords

Nitric oxide; Rat carotid; Superoxide anions; Vitamin K1

Indexed keywords

7 NITROINDAZOLE; ACETYLCHOLINE; ARGININE; BRADYKININ; INDOMETACIN; LUCIGENIN; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PHENYLEPHRINE; PHYTOMENADIONE; SUPEROXIDE; TIRON; VITAMIN;

ANIMAL TISSUE; ARTICLE; ASSAY; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; CAROTID ARTERY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; VASOMOTOR DISORDER; VASOMOTOR REFLEX; ANIMAL; DRUG EFFECT; MUSCLE CONTRACTION; MUSCLE RELAXATION; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALIA;

ANIMALS; CAROTID ARTERIES; ENDOTHELIUM, VASCULAR; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; OXIDATIVE STRESS; RATS; RATS, WISTAR; VITAMIN K 1; VITAMINS;

EID: 33646153517     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.09.001     Document Type: Article

References (37)

1. Alexander R.W. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25 (1995) 155-161
2. Ballejo G., Barbosa T.A., Coelho E.B., Antoniali C., and Salgado M.C. Pregnancy-associated increase in rat systemic arteries endothelial nitric oxide production diminishes vasoconstrictor but does not enhance vasodilator responses. Life Sci. 70 (2002) 3131-3142
3. Batenburg W.W., Popp R., Fleming I., de Vries R., Garrelds I.M., Saxena P.R., and Danser A.H. Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF? Br. J. Pharmacol. 142 (2004) 125-135
4. Boor P.J., Gotlieb A.I., Joseph E.C., Kerns W.D., Roth R.A., and Tomaszewski K.T. Contemporary issues in toxicology: chemical-induced vasculature injury. Toxicol. Appl. Pharmacol. 132 (1995) 177-195
5. Brandes R.P., Barton M., Philippens K.M.H., Schweitzer G., and Mügge A. Endothelial-derived superoxide anion in pig coronary arteries; evidence from lucigenin chemiluminescence and histochemical techniques. J. Physiol. 500 (1997) 331-342
6. Cadenas E. Biochemistry of oxygen toxicity. Annu. Rev. Biochem. 58 (1989) 79-110
7. Chung J.H., Seo D.C., Chung S.H., Lee J.Y., and Seung S.A. Metabolism and cytotoxity of menadione and its metabolite in rat platelets. Toxicol. Appl. Pharmacol. 142 (1997) 378-385
8. Dayal S., Arning E., Bottiglieri T., Boger R.H., Sigmund C.D., Faraci F.M., and Lentz S.R. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke 35 (1957) 1957-1962
9. Faulkner K.M., Liochev S.I., and Fridovich I. Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J. Biol. Chem. 269 (1994) 23471-23476
10. Gallop P.M., Lian J.B., and Hauschka P.V. Carboxylated calcium-binding proteins and vitamin K. N. Engl. J. Med. 302 (1980) 1460-1466
11. Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1 (1987) 358-364
12. Hammond B., Kontos H.A., and Hess M.L. Oxygen radicals in the adult respiratory distress syndrome, in myocardial ischemia and reperfusion injury, and in cerebral vascular damage. Can. J. Physiol. Pharmacol. 63 (1985) 173-187
13. Hayashi T., Fukuto J.M., Ignarro L.J., and Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 11259-11263
14. Hsu K., and Lin-Shiau S. Antagonism by paraquat of the relaxing effects of acetylcholine and A23187 in rat thoracic aorta. Eur. J. Pharmacol. 292 (1995) 315-320
15. Ignarro L.J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 535-560
16. Kaw S., and Hecker M. Endothelium-derived hyperpolarizing factor, but not nitric oxide or prostacyclin release, is resistant to menadione-induced oxidative stress in the bovine coronary artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 359 (1999) 133-139
17. Kumagai Y., Nakajima H., Midorikawa K., Homma-Takeda S., and Shimojo N. Inhibition of nitric oxide formation by neuronal nitric oxide synthase by quinines: nitric oxide synthase as a quinine reductase. Chem. Res. Toxicol. 11 (1998) 608-613
18. Lee J.Y., Lee M.Y., Chung S.M., and Chung J.H. Menadione-induced vascular endothelial dysfunction and its possible significance. Toxicol. Appl. Pharmacol. 161 (1999) 140-145
19. Lee J.A., Jung S.H., Bae M.K., Ryu C.K., Lee J.Y., Chung J.H., and Kim H.J. Pharmacological effects of novel quinone compounds, 6-(fluorinated-phenyl)amino-5,8-quinolinediones, on inhibition of drug-induced relaxation of rat aorta and their putative action mechanism. Gen. Pharmacol. 34 1 (2000 (Jan.)) 33-42
20. Lee J.L., Bae O.N., Chung S.M., Lee M.Y., and Chung J.H. Menadione induces endothelial dysfunction mediated by oxidative stress and arylation. Chem. Biol. Interact. 137 2 (2001 (Aug. 31)) 169-183
21. Lefer A.M., Tsao P.S., and Ma X.L. Shock- and ischemia-induced mechanisms of impairment of endothelium-mediated vasodilation. Chest 100 3 Suppl. (1991 (Sep.)) 160S-163S Review. No abstract available
22. Li Y., Zhu H., Kuppusamy P., Roubaud V., Zweier J., and Trush M.A. Validation of lucigenin (Bis-N-Methylacridinium) as a chemiluminescent probe for detecting Superoxide anion radical for detecting superoxide anion radical production by enzimatic and cellular sources. J. Biol. Chem. 273 (1998) 2015-2023
23. Luscher T.F., Tanner F.C., Tschundi M.R., and Noll G. Endothelial dysfunction in coronary artery disease. Annu. Rev. Med. 44 (1993) 395-418
24. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
25. 1. Biochem. Pharmacol. 35 (1986) 4273-4281
26. Powis G. Free radical formation by antitumor quinines. Free Radical Biol. Med. 6 (1989) 63-101
27. Raith W., Fauler G., Pichler G., and Muntean W. Plasma concentrations after intravenous administration of phylloquinone (vitamin K1) in preterm and sick neonates. Thrombosis Res. 99 (2000) 467-472
28. Rossi L., Moore G.A., Orrenius S., and O'Brien P.J. Quinone toxicity in hepatocytes without oxidative stress. Arch. Biochem. Biophys. 251 (1986) 25-35
29. Rubanyi G.M. The role of endothelium in cardiovascular homeostasis and diseases. J. Cardiovasc. Pharmacol. 22 Suppl. 4 (1993) S1-S14
30. 1 prophylaxix for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland. Eur. J. Pediatr. 158 (1999) 599-602
31. Sellke F.W., Boyle E.M., and Varrier E.D. The pathophysiology of vasomotor dysfunction. Ann. Thorac. Surg. 64 (1997) S9-S15
32. Sendão Oliveira A.P., and Bendhack L.M. Relaxation induced by acetylcholine involves endothelium-derived hyperpolarizing factor in 2-kidney 1-clip hypertensive rat carotid arteries. Pharmacology 72 (2004) 231-239
33. Shearer M.J. Vitamin K. Lancet 345 (1995) 229-234
34. 1 prevents the effect of hypoxia on phenylephrine-induced contraction in the carotid artery. Pharmacology 66 (2002) 36-43
35. Tirapelli C.R., Mingatto F.E., de Godoy M.A.F., Ferreira R., and de Oliveira A.M. Vitamin K1 attenuates hypoxia-induced relaxation of rat carotid artery. Pharmacol. Res. 46 (2002) 483-490
36. Vanhoutte P.M. Endothelial dysfunction and atherosclerosis. Eur. Heart J. 18 Suppl. E (1997 (Nov.)) E19-E29 Review
37. Vasquez-Vivar J., Martasek P., Hogg N., Masters B.S., Pritchard Jr. K.A., and Kalyanaraman B. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 36 38 (1997 (Sep. 23)) 11293-11297